Clinical trial
TP-38 Toxin in Treating Young Patients With Recurrent or Progressive…
NCT00074334 · Pediatric Brain Tumor Consortium, Other · Terminated
Key facts
| NCT number | NCT00074334 |
|---|---|
| Title | TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma |
| Official title | A Phase I/II Study Of A Recombinant Chimeric Protein Composed Of Transforming Growth Factor (TGF)-a And A Mutated Pseudomonas Exotoxin Termed PE38 (TP-38) In Pediatric Patients With Recurrent Or Progressive Supratentorial High Grade Gliomas |
| Lead sponsor | Pediatric Brain Tumor Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Procedure |
| Interventions | TGFa-PE38 immunotoxin, conventional surgery |
| Enrollment | 3 |
| Start date | May 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Dec 11, 2003 |
| Last update posted | Oct 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: